Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manthena V S Varma

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Clinical Pharmacology and Therapeutics|June 20, 2022
Clinical Relevance of Organic Anion Transporting Polypeptide 1B-Mediated Hepatic Uptake for High-Permeability Drugs: A PerspectiveManthena V S Varma
Expert Opinion on Drug Metabolism & Toxicology|April 18, 2023
Genetic variation in organic cation transporters and considerations in drug developmentManthena V S Varma
Journal of Pharmaceutical Sciences|June 30, 2005
Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeabilityManthena V S Varma, Ramesh Panchagnula
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 14, 2005
Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivoManthena V S Varma, Ramesh Panchagnula
Clinical Pharmacology and Therapeutics|January 14, 2025
Navigating the Challenges of Cyclosporine as an Alternative to Rifampicin as an OATP1B Index InhibitorManthena V S Varma, Manoli Vourvahis
Journal of Pharmaceutical Sciences|November 1, 2005
pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situManthena V S Varma, Ramesh Panchagnula
Molecular Pharmaceutics|June 27, 2020
Cytochrome-P450-Mediated Drug<b>-</b>Drug Interactions of Substrate Drugs: Assessing Clinical Risk Based on Molecular Properties and an Extended Clearance Classification SystemStefanus J Steyn, Manthena V S Varma
Molecular Pharmaceutics|April 5, 2005
Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transportManthena V S Varma, Khandavilli Sateesh, Ramesh Panchagnula
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2018
Navigating Transporter Sciences in Pharmacokinetics Characterization Using the Extended Clearance Classification SystemAyman F El-Kattan, Manthena V S Varma
Clinical Pharmacology and Therapeutics|March 26, 2025
Hepatic Impairment and the Differential Effects on Drug Clearance Mechanisms: Analysis of Pharmacokinetic Changes in Disease StateLloyd Wei Tat Tang, Manthena V S Varma
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Clinical Pharmacology and Therapeutics|June 20, 2022
Clinical Relevance of Organic Anion Transporting Polypeptide 1B-Mediated Hepatic Uptake for High-Permeability Drugs: A PerspectiveManthena V S Varma
Expert Opinion on Drug Metabolism & Toxicology|April 18, 2023
Genetic variation in organic cation transporters and considerations in drug developmentManthena V S Varma
Journal of Pharmaceutical Sciences|June 30, 2005
Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeabilityManthena V S Varma, Ramesh Panchagnula
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 14, 2005
Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivoManthena V S Varma, Ramesh Panchagnula
Clinical Pharmacology and Therapeutics|January 14, 2025
Navigating the Challenges of Cyclosporine as an Alternative to Rifampicin as an OATP1B Index InhibitorManthena V S Varma, Manoli Vourvahis
Journal of Pharmaceutical Sciences|November 1, 2005
pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situManthena V S Varma, Ramesh Panchagnula
Molecular Pharmaceutics|June 27, 2020
Cytochrome-P450-Mediated Drug<b>-</b>Drug Interactions of Substrate Drugs: Assessing Clinical Risk Based on Molecular Properties and an Extended Clearance Classification SystemStefanus J Steyn, Manthena V S Varma
Molecular Pharmaceutics|April 5, 2005
Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transportManthena V S Varma, Khandavilli Sateesh, Ramesh Panchagnula
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2018
Navigating Transporter Sciences in Pharmacokinetics Characterization Using the Extended Clearance Classification SystemAyman F El-Kattan, Manthena V S Varma
Clinical Pharmacology and Therapeutics|March 26, 2025
Hepatic Impairment and the Differential Effects on Drug Clearance Mechanisms: Analysis of Pharmacokinetic Changes in Disease StateLloyd Wei Tat Tang, Manthena V S Varma
Pageof 10